𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preparation and evaluation of poly-butylcyanoacrylate nanoparticles for oral delivery of thymopentin

✍ Scribed by Weiling He; Xuehua Jiang; Zhi-Rong Zhang

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
201 KB
Volume
97
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

✦ Synopsis

Thymopentin (Tp5) was loaded in poly-butylcyanoacrylate (PBCA) nanoparticles (NP) in order to enhance the oral bioavailability of Tp5. PBCA-Tp5-NP was prepared by nanoprecipitation methods. Dialyzing membrane method was employed to examine the in vitro release of PBCA-Tp5-NP in PBS, and Tp5 samples in the release medium were detected by HPLC. The cell proliferation test ((3)H-thymidine) was conducted to verify the PBCA-Tp5-NP bioactivity in vitro. The pharmacodynamical studies were performed on preimmunoinhibited rats and in flow cytometer. The size and the entrapment efficiency of PBCA-Tp5-NP were 178 +/- 39 nm and 92.21 +/- 1.08%, respectively. In vitro release data show that less than 60% Tp5 was released from lyophilized PBCA-Tp5-NP while 80% Tp5 was released from the colloidal PBCA-Tp5-NPs in 48 h. The proliferation test showed that PBCA-Tp5-NP had the similar effect as Tp5. The in vivo data showed that oral PBCA-Tp5-NPs had similar function as what intravenous Tp5 did. The oral bioavailability of Tp5 could be enhanced by PBCA nanoparticles. PBCA-Tp5-NP had the property of sustained-release and the efficacy of Tp5 was not changed after formulation.

📜 SIMILAR VOLUMES

Preparation of insulin loaded PLGA-Hp55
Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery
✍ Fu-de Cui; An-jin Tao; Dong-mei Cun; Li-qiang Zhang; Kai Shi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

The aim of the present work was to investigate the preparation of PLGA nanoparticles (PNP) and PLGA-Hp55 nanoparticles (PHNP) as potential drug carriers for oral insulin delivery. The nanoparticles were prepared by a modified emulsion solvent diffusion method in water, and their physicochemical char

Poly(ε-caprolactone)/eudragit nanopartic
Poly(ε-caprolactone)/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes
✍ Christiane Damgé; Marie Socha; Nathalie Ubrich; Philippe Maincent 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB

Nanoparticles prepared with a blend of a biodegradable polyester (poly(epsilon-caprolactone)) and a polycationic nonbiodegradable acrylic polymer (Eudragit RS) have been used as a drug carrier for oral administration of a short-acting insulin analogue, aspart-insulin. Insulin-loaded nanoparticles, a

One-step preparation of poly(ϵ-caprolact
One-step preparation of poly(ϵ-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanoparticles for plasmid DNA delivery
✍ Mei Juan Huang; Ma Ling Gou; Zhi Yong Qian; Mei Dai; Xing Yi Li; Mei Cao; Ke Wan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

## Abstract In this article, a kind of biodegradable poly(ϵ‐caprolactone)‐Poly(ethylene glycol)‐poly(ϵ‐caprolactone) (PCL‐PEG‐PCL, PCEC) copolymer was synthesized by ring‐opening polymerization method. The PCEC nanoparticles were prepared at one‐step by modified emulsion solvent evaporation method